Islet Cell Tumors (Pancreatic) Treatment - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Islet Cell Tumors (Endocrine Pancreas) (PDQ®)

Patient Version

Health Professional Version

En español

Last Modified: 08/07/2009


General Information About Islet Cell Tumors (Endocrine Pancreas)


Stages of Islet Cell Tumors (Endocrine Pancreas)


		Recurrent Islet Cell Tumors (Endocrine Pancreas)


Treatment Option Overview


Treatment Options for Islet Cell Tumors (Endocrine Pancreas)


To Learn More About Islet Cell Tumors (Endocrine Pancreas)


Get More Information From NCI


Changes to This Summary (08/07/2009)


About PDQ

Page Options

Print This Page

Print This Document

View Entire Document

E-Mail This Document

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp online chat

Quit Smoking Today

	NCI Highlights


	Office of Biorepositories and Biospecimen Research The Nation's Investment in Cancer Research FY 2010 Report to Nation Finds Declines in Cancer Incidence, Death Rates

Recurrent Islet Cell Tumors (Endocrine Pancreas)

Recurrent islet cell tumors are tumors that have recurred (come back) after being treated. The tumors may come back in the pancreas or in other parts of the body.

< Previous Section | Next Section >

| | | | | | | | |

A Service of the National Cancer Institute